Healthcare body seeks regulatory reforms in meeting with Niti Aayog

Nathealth has proposed a digital single-window system to Niti Aayog to ease the healthcare sector's compliance load, citing inefficiencies and duplication across ministries

nathealth
To tackle this, the industry has sought a digital single-window platform for end-to-end compliance with deemed approvals and well-defined timelines.
Sanket Koul New Delhi
2 min read Last Updated : Jul 28 2025 | 10:04 PM IST
Healthcare industry body Nathealth on Monday sought regulatory reforms for the hospital, diagnostics, and medical device sectors in a meeting with Niti Aayog, after the planning body had asked for the industry’s suggestions on reducing compliance burdens for healthcare facilities in the country.
 
In a white paper submitted to Niti Aayog, Nathealth said the healthcare industry is currently subject to oversight from 10 to 12 ministries and three tiers of governance at the central, state, and municipal levels.
 
“Multiple discussions have happened with different ministries and bodies in streamlining compliance issues before submitting the white paper,” an official with the industry body said.
 
Calling the segment one of the top three regulated sectors in India, the industry body added that around 24 per cent of regulations applicable to the sector are healthcare-specific.
 
“Twenty-five to thirty per cent of compliance requirements change each year in the healthcare sector, creating operational and system inefficiencies, draining time and resources from patient care, clinical excellence, and innovation,” it said.
 
To tackle this, the industry has sought a digital single-window platform for end-to-end compliance with deemed approvals and well-defined timelines. 
 
This, it said, would help in the harmonisation of regulations across states and departments and ensure clear delineation of roles between central and state authorities.
 
The white paper also identified 85 key compliance challenges across hospitals, diagnostic centres, and medtech companies, of which 44 were flagged as particularly onerous, either due to duplication, lack of clarity, or administrative inefficiency.
 
This includes compliance with multiple quality control orders (QCOs), which may lead to delays in medical device registrations and approvals, along with no defined timelines or guidance on seeking approvals for healthcare professionals (HCPs) travelling for an event.
 
The body also pointed out that there is a lack of standardisation in clinical establishment regulations across states, with little clarity on basic issuance or rejection of lift licences and building height rules.
 
Nathealth President Ameera Shah said that as the sector scales, it is essential to have regulatory frameworks that are agile, forward-looking, and aligned with the needs of patient-centred care.
 
“The white paper reflects the sector’s collective intent to partner with policymakers in strengthening standards through smart, technology-driven solutions,” she added.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :NathealthIndian healthcarePharma industryNiti Aayog

First Published: Jul 28 2025 | 10:04 PM IST

Next Story